Literature DB >> 16476896

Association of adipose and red blood cell lipids with severity of dominant Stargardt macular dystrophy (STGD3) secondary to an ELOVL4 mutation.

Amy F Hubbard1, E Wayne Askew, Nanda Singh, Mark Leppert, Paul S Bernstein.   

Abstract

OBJECTIVE: To determine whether adipose and red blood cell membrane lipids, particularly long-chain polyunsaturated fatty acids such as docosahexaenoic acid and eicosapentaenoic acid, are significantly correlated with phenotype in a family with autosomal dominant Stargardt macular dystrophy (gene locus STGD3). A mutation in the ELOVL4 gene is responsible for the macular dystrophy in this family, and its disease-causing mechanism may be its possible involvement in fatty acid elongation in the retina.
METHODS: The subjects in this study included 18 adult family members known to have a 2-base pair deletion in the ELOVL4 gene. Control subjects included 26 family members without the mutation. Each subject received a complete eye examination including fundus photographs, the results of which were used to grade the severity of macular dystrophy on a 3-tier scale. Red blood cell membrane and adipose tissue lipids were analyzed as an indication of short-term and long-term dietary fatty acid intake.
RESULTS: When adipose lipids were analyzed, there was a significant inverse relationship between phenotypic severity and the level of eicosapentaenoic acid (r = -0.54; P = .04). When red blood cell lipids were analyzed, there were significant inverse relationships between phenotypic severity and levels of eicosapentaenoic acid (r = -0.55; P = .02) and docosahexaenoic acid (r = -0.48; P = .04).
CONCLUSIONS: These results indicate that the phenotypic diversity in this family may be related to differences in dietary fat intake as reflected by adipose and red blood cell lipids. CLINICAL RELEVANCE: This study demonstrates that dietary factors can influence the severity of an inherited human macular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476896     DOI: 10.1001/archopht.124.2.257

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  17 in total

1.  Long-chain and very long-chain polyunsaturated fatty acids in ocular aging and age-related macular degeneration.

Authors:  Aihua Liu; James Chang; Yanhua Lin; Zhengqing Shen; Paul S Bernstein
Journal:  J Lipid Res       Date:  2010-08-05       Impact factor: 5.922

2.  Haploinsufficiency is not the key mechanism of pathogenesis in a heterozygous Elovl4 knockout mouse model of STGD3 disease.

Authors:  Dorit Raz-Prag; Radha Ayyagari; Robert N Fariss; Md Nawajes A Mandal; Vidyullatha Vasireddy; Sharon Majchrzak; Andrea L Webber; Ronald A Bush; Norman Salem; Konstantin Petrukhin; Paul A Sieving
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

3.  n-3 PUFA Supplementation Alters Retinal Very-Long-Chain-PUFA Levels and Ratios in Diabetic Animal Models.

Authors:  Aruna Gorusupudi; Fu-Yen Chang; Kelly Nelson; Gregory S Hageman; Paul S Bernstein
Journal:  Mol Nutr Food Res       Date:  2019-06-28       Impact factor: 5.914

4.  Retinal bioavailability and functional effects of a synthetic very-long-chain polyunsaturated fatty acid in mice.

Authors:  Aruna Gorusupudi; Rameshu Rallabandi; Binxing Li; Ranganathan Arunkumar; J David Blount; Gregory T Rognon; Fu-Yen Chang; Alexander Wade; Steven Lucas; John C Conboy; Jon D Rainier; Paul S Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

5.  Mouse Models of Stargardt 3 Dominant Macular Degeneration.

Authors:  Peter Barabas; Aruna Gorusupudi; Paul S Bernstein; David Krizaj
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

6.  DHA supplementation for late onset Stargardt disease: NAT-3 study.

Authors:  Giuseppe Querques; Pascale Benlian; Bernard Chanu; Nicolas Leveziel; Gabriel Coscas; Gisele Soubrane; Eric H Souied
Journal:  Clin Ophthalmol       Date:  2010-07-21

7.  Inner retina remodeling in a mouse model of stargardt-like macular dystrophy (STGD3).

Authors:  Sharee Kuny; Frédéric Gaillard; Silvina C Mema; Paul R Freund; Kang Zhang; Ian M Macdonald; Janet R Sparrow; Yves Sauvé
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

8.  Long-term follow-up of autosomal dominant Stargardt macular dystrophy (STGD3) subjects enrolled in a fish oil supplement interventional trial.

Authors:  Rene Choi; Aruna Gorusupudi; Paul S Bernstein
Journal:  Ophthalmic Genet       Date:  2018-01-29       Impact factor: 1.803

9.  Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration.

Authors:  Peter Barabas; Aihua Liu; Wei Xing; Ching-Kang Chen; Zongzhong Tong; Carl B Watt; Bryan W Jones; Paul S Bernstein; David Križaj
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

Review 10.  Genetics and molecular pathology of Stargardt-like macular degeneration.

Authors:  Vidyullatha Vasireddy; Paul Wong; Radha Ayyagari
Journal:  Prog Retin Eye Res       Date:  2010-01-21       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.